Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration
December 13, 2022 16:01 ET
|
Praxis Precision Medicines, Inc.
BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, and UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical...